Daniel R. CherñavvskyDaniel R. Cherñavvsky is Assistant Professor of Research in the Center for Diabetes Technology at the University of Virginia. The Center for Diabetes Technology is a multidisciplinary group of research academicians with specialties in Pediatrics, Endcrinology, Behavioral Medicine, Systems Engineering, Mathematics, and Statistics, working collaboratively for the advancement of technology for the treatment of type 1 diabetes. Currently, Dr. Cherñavvsky is leading several artificial pancreas studies in pediatric and young adult populations. In addition, Dr. Cherñavvsky collaborates with the International Artificial Pancreas (iAP) Study Group, which joins investigators from Italy, France, Israel, Argentina, and the USA. He had conducted the first-ever outpatient clinical study of a cell phone-based artificial pancreas system and performed US and international outpatients-based trials with different generations of the Artificial Pancreas system. Dr. Cherñavvsky’s funded studies include summer and winter camps with adolescents evaluating the effect of exercise and type 1 diabetes. Dr. Cherñavvsky, a pediatric nephrologist and pediatric intensive care specialist graduate from the University of Buenos Aires, has conducted and designed clinical research projects for over 15 years in the USA. Since September 2016, he joined TypeZero Technologies, Inc., as a part time chief medical officer. Now he divides his time between academia, continuing his clinical research activities, and industry, where he is moving forward technological products aiming to optimize treatment for people with type 1 diabetes. Read More Read Less